PMV Pharmaceuticals (PMVP) Competitors

Shattuck Labs (NASDAQ:STTK) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends.

Is STTK or PMVP more profitable?

PMV Pharmaceuticals has a net margin of 0.00% compared to Shattuck Labs' net margin of -2,067.99%. PMV Pharmaceuticals' return on equity of -21.96% beat Shattuck Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shattuck Labs	-2,067.99%	-68.65%	-60.38%
PMV Pharmaceuticals	N/A	-21.96%	-19.80%

Which has more volatility & risk, STTK or PMVP?

Shattuck Labs has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.52, suggesting that its share price is 52% more volatile than the S&P 500.

Do insiders & institutionals believe in STTK or PMVP?

58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are held by institutional investors. 10.5% of Shattuck Labs shares are held by insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Do analysts rate STTK or PMVP?

Shattuck Labs presently has a consensus price target of $8.67, suggesting a potential upside of 462.77%. PMV Pharmaceuticals has a consensus price target of $5.75, suggesting a potential upside of 285.91%. Given Shattuck Labs' higher probable upside, analysts plainly believe Shattuck Labs is more favorable than PMV Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shattuck Labs	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.40
PMV Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Which has higher valuation and earnings, STTK or PMVP?

PMV Pharmaceuticals has lower revenue, but higher earnings than Shattuck Labs. PMV Pharmaceuticals is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shattuck Labs	$1.66M	44.28	-$87.30M	-$1.85	-0.83
PMV Pharmaceuticals	N/A	N/A	-$68.96M	-$0.97	-1.54

Does the MarketBeat Community prefer STTK or PMVP?

Shattuck Labs received 15 more outperform votes than PMV Pharmaceuticals when rated by MarketBeat users. Likewise, 74.00% of users gave Shattuck Labs an outperform vote while only 61.11% of users gave PMV Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Shattuck Labs	Outperform Votes 37 74.00%	Underperform Votes 13 26.00%
PMV Pharmaceuticals	Outperform Votes 22 61.11%	Underperform Votes 14 38.89%

Does the media refer more to STTK or PMVP?

In the previous week, Shattuck Labs had 2 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 6 mentions for Shattuck Labs and 4 mentions for PMV Pharmaceuticals. Shattuck Labs' average media sentiment score of 1.02 beat PMV Pharmaceuticals' score of 0.94 indicating that Shattuck Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Shattuck Labs	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PMV Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Shattuck Labs beats PMV Pharmaceuticals on 9 of the 17 factors compared between the two stocks.